2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions

View by Date

Wednesday, November 16, 2016

9:00AM-10:30AM: Abstract Number: 3179

Scale Structure and Measurement Properties of a Disease Specific Patient-Reported Outcome for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Vasculitis IV: Diagnosis and Assessment of Disease Activity

9:00AM-10:30AM: Abstract Number: 3160

Scoring Syndesmophytes on CT Spine Images of Patients with Radiographic Axial Spondyloarthritis from the Sensitive Imaging of Axial Spondyloarthritis (SIAS) Cohort

Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment V: Imaging of Spondyloarthritis

9:00AM-10:30AM: Abstract Number: 3163

SEC16A and Intracellular Trafficking Abnormalities in Axial Spondyloarthritis

Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology II

9:00AM-10:30AM: Abstract Number: 3125

Secular Trend of Premature Mortality in Gout: A Contrast from Rheumatoid Arthritis

Metabolic and Crystal Arthropathies II: Clinical Practice

9:00AM-10:30AM: Abstract Number: 3146

Selective Deletion of a Pathogenic Subset Synovial Fibroblasts Attenuates Synovial Inflammation

Rheumatoid Arthritis – Animal Models II

9:00AM-10:30AM: Abstract Number: 3121

Specific Antibody Subphenotypes in Rheumatoid Arthritis Are Associated with Unique HLA-DRB1 Residues at Position 11

Genetics, Genomics and Proteomics II

9:00AM-10:30AM: Abstract Number: 3164

Spondyloarthritis Pathogenesis Involves Interplay Between Gut Microbiota and Genetic Background

Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology II

9:00AM-10:30AM: Abstract Number: 3138

Sustained Improvement in Follow-up of Hypertension in Rheumatology Patients: Results of an Intervention Sustainability Assessment

Quality Measures and Quality of Care II

9:00AM-10:30AM: Abstract Number: 3162

Symmetric and Asymmetric Sacroiliitis Are Associated with Different Major Histocompatibility Class I Alleles in Psoriatic Arthritis

Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology II

9:00AM-10:30AM: Abstract Number: 3177

Targeted Nuclear Imaging for the Early Detection of Lung Involvement in Systemic Sclerosis

Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics II

9:00AM-10:30AM: Abstract Number: 3172

Temporal Trends in SLE Mortality According to Sex, Race, Ethnicity, and Geographic Region in the United States over the Past Five Decades

Systemic Lupus Erythematosus – Clinical Aspects and Treatment V: Damage and Morbidity

9:00AM-10:30AM: Abstract Number: 3161

The Association Between HLA Genetic Susceptibility Markers and Sonographic Enthesitis in Psoriatic Arthritis

Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology II

9:00AM-10:30AM: Abstract Number: 3157

The Association Between Sonographic Enthesitis and Radiographic Damage in Psoriatic Arthritis

Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment V: Imaging of Spondyloarthritis

9:00AM-10:30AM: Abstract Number: 3143

The Caspase 8/RIPK3 Signaling Axis in Dendritic Cells Controls Joint Homeostasis Under Steady-State and Arthritic Conditions

Rheumatoid Arthritis – Animal Models II

9:00AM-10:30AM: Abstract Number: 3151

The Diagnostic and Predictive Value of Anti-Acetylated Peptide Antibodies in RA Patients Starting Methotrexate Treatment

Rheumatoid Arthritis – Clinical Aspects VI: Management of Early Rheumatoid Arthritis

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].